Search clinical trials for: 1- First time clinical ischemic or hemorrhagic stroke
Total 270987 results
-
Tianjin Medical University Cancer Institute and...Recruiting
-
Haruhiko FukudaMinistry of Health, Labour and Welfare, JapanCompletedUterine Cervical NeoplasmsJapan
-
Ningbo No. 1 HospitalNot yet recruitingType 2 Diabetes Mellitus | Acute Coronary SyndromeChina
-
Ningbo No. 1 HospitalRecruitingObesity | PreDiabetesChina
-
Eli Lilly and CompanyActive, not recruitingType 2 Diabetes | T2DUnited States, Mexico, Argentina, Puerto Rico
-
Haruhiko FukudaMinistry of Health, Labour and Welfare, JapanCompleted
-
Ankara Yildirim Beyazıt UniversityRecruitingStroke | Exoskeleton Device | LocomotionTurkey
-
Ningbo No. 1 HospitalRecruiting
-
Ningbo No. 1 HospitalNot yet recruitingNonalcoholic Fatty Liver DiseaseChina
-
Ningbo No. 1 HospitalCompletedNonalcoholic Fatty Liver Disease | Type2 Diabetes Mellitus | Light-to-moderate Alcohol ConsumptionChina
-
Japan Clinical Oncology GroupMinistry of Health, Labour and Welfare, JapanCompletedOvarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal NeoplasmsJapan
-
Eli Lilly and CompanyNot yet recruiting
-
Haruhiko FukudaMinistry of Health, Labour and Welfare, JapanCompleted
-
Pathalys PharmaLaunch TherapeuticsRecruitingSecondary Hyperparathyroidism | End-stage Kidney Disease (ESKD)United States, Bulgaria, Spain, Portugal, Poland, Serbia
-
Eli Lilly and CompanyRecruitingHealthy | Type 1 Diabetes MellitusGermany
-
Eli Lilly and CompanyActive, not recruiting
-
Zhujiang HospitalNot yet recruitingEfficacy Endpoint: no New Cerebrovascular Adverse Events Within 1 Year | Safety Endpoint: no New Moderate or Serious Adverse Events Within 1 Year | All-cause Mortality Events (Within 1 Year) | Incident Ischemic Stroke Events (Within 1 Year) | New Hemorrhagic Stroke Events (Within 1 Year) | New... and other conditions
-
Eli Lilly and CompanyCompletedType 1 Diabetes MellitusSpain, United States, France, Israel, Australia, Germany, Italy, Puerto Rico, Austria, Hungary, Canada
-
EZUS-LYON 1Active, not recruiting
-
University of PlymouthVeeda Clinical Research; Organon TeknikaCompleted
-
Haruhiko FukudaMinistry of Health, Labour and Welfare, JapanCompleted
-
Ningbo No. 1 HospitalNot yet recruiting
-
Ningbo No. 1 HospitalRecruiting
-
Ningbo No. 1 HospitalRecruitingCovid19 | Knowledge, Attitudes, PracticeChina
-
Ningbo No. 1 HospitalCompletedType 2 Diabetes | Nonalcoholic Fatty Liver DiseaseChina
-
Eli Lilly and Companyi3 Drug SafetyCompletedTransient Ischemic Attack | ADHD | Cerebrovascular AccidentUnited States
-
Haruhiko FukudaMinistry of Health, Labour and Welfare, JapanCompleted
-
Haruhiko FukudaMinistry of Health, Labour and Welfare, JapanCompletedColorectal NeoplasmsJapan
-
Japan Clinical Oncology GroupMinistry of Health, Labour and Welfare, JapanTerminatedA Trial of Chemotherapy Before and After Surgery for Stage II,III Esophageal Squamous Cell CarcinomaCarcinoma, Squamous Cell | Esophageal NeoplasmsJapan
-
Haruhiko FukudaMinistry of Health, Labour and Welfare, JapanCompletedGastric NeoplasmJapan
-
Uro-1 MedicalRecruiting
-
Uro-1 MedicalRecruiting
-
Alpha-1 FoundationRecruiting
-
Eli Lilly and CompanyActive, not recruitingUrogenital Neoplasms | Prostatic Neoplasms | Neoplasm Metastasis | Enzyme Inhibitors | Antineoplastic Agents | Hormones | Physiological Effects of Drugs | Antineoplastic Agents, Hormonal | Androgens | Hormones, Hormone Substitutes, and Hormone Antagonists | Abiraterone Acetate | Steroid Synthesis Inhibitors | Cytochrome... and other conditionsChina, Canada, France, United States, Australia, Czechia, Hungary, Spain, Germany, Japan, Taiwan, Netherlands, Turkey, Mexico, Belgium, Korea, Republic of, Argentina, Romania, United Kingdom, Italy, Israel, Brazil, Poland, Greece
-
Haruhiko FukudaMinistry of Health, Labour and Welfare, JapanCompleted
-
Haruhiko FukudaMinistry of Health, Labour and Welfare, JapanCompleted
-
OSCAR StudyJapan Heart FoundationCompletedCardiovascular Diseases | HypertensionJapan
-
Cleveland Medical Devices IncNational Institute of Neurological Disorders and Stroke (NINDS)CompletedELECTROENCEPHALOGRAPHIC VARIANT PATTERN 1 (Disorder)United States
-
Clinical Institute of the Brain, RussiaUnknownIschemic StrokeRussian Federation
-
Uro-1 MedicalNot yet recruiting
-
Children's Hospital 1RecruitingTotal Anomalous Pulmonary Venous Connection | Pulmonary Venous Stenosis | Sutureless ClosureVietnam
-
Alpha-1 FoundationCompletedChronic Obstructive Pulmonary Disease | Alpha-1 Antitrypsin DeficiencyUnited States, Puerto Rico
-
Kitasato UniversityYokohama City University Medical Center; St. Marianna University School of... and other collaboratorsUnknownHypertension | Type 2 Diabetes MellitusJapan
-
National University Hospital, SingaporeThe N.1 Institute for Health (N.1)Recruiting
-
Eli Lilly and CompanyActive, not recruitingObesity | OverweightSpain, United States, Australia, Italy, Hungary, India, Israel, Canada, China, Taiwan, Japan, United Kingdom, Belgium, France, Germany, Mexico, Romania, Poland, Argentina, Brazil, Puerto Rico, Austria, Turkey, Netherlands, Korea, Republic... and more
-
Eli Lilly and CompanyActive, not recruitingObesity | Heart Failure With Preserved Ejection Fraction (HFpEF)China, United States, Taiwan, Mexico, Brazil, Puerto Rico, Argentina, Israel, India, Russian Federation
-
Eli Lilly and CompanyActive, not recruitingImmune System Diseases | Autoimmune Diseases | Arthritis | Joint Diseases | Musculoskeletal Diseases | Rheumatic Diseases | Connective Tissue Diseases | Rheumatoid ArthritisUnited States, Spain, China, Mexico, Puerto Rico, Japan, Canada, Argentina, Poland, Hungary, Greece
-
Eli Lilly and CompanyActive, not recruitingUlcerative ColitisSpain, United States, China, Australia, Austria, Japan, Hungary, Taiwan, Russian Federation, Canada, Korea, Republic of, Italy, Belgium, Poland, Switzerland, Argentina, India, Israel, Latvia, Ukraine, Denmark, Mexico, Romania, Malaysia, Netherland... and more
-
Eli Lilly and CompanyCompletedLipoprotein DisorderAustralia, China, Hungary, Brazil, Japan, Germany, Netherlands, United States